Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Impact of an Opioid Safety Initiative on Patients Undergoing Total Knee Arthroplasty: A Time Series Analysis.

Chen Q, Hsia HL, Overman R, Bryan W, Pepin M, Mariano ER, Mudumbai SC, Buchheit T, Krishnamoorthy V, Good CB, Brookhart MA, Raghunathan K.

Anesthesiology. 2019 Aug;131(2):369-380. doi: 10.1097/ALN.0000000000002771.

PMID:
31314748
2.

G-estimation of structural nested mean models for competing risks data using pseudo-observations.

Tanaka S, Brookhart MA, Fine JP.

Biostatistics. 2019 May 6. pii: kxz015. doi: 10.1093/biostatistics/kxz015. [Epub ahead of print]

PMID:
31056651
3.

Using Instrumental Variables to Address Bias From Unobserved Confounders.

Maciejewski ML, Brookhart MA.

JAMA. 2019 May 2. doi: 10.1001/jama.2019.5646. [Epub ahead of print] No abstract available.

PMID:
31046064
4.

Safety of Dynamic Intravenous Iron Administration Strategies in Hemodialysis Patients.

Li X, Cole SR, Kshirsagar AV, Fine JP, Stürmer T, Brookhart MA.

Clin J Am Soc Nephrol. 2019 May 7;14(5):728-737. doi: 10.2215/CJN.03970318. Epub 2019 Apr 15.

PMID:
30988164
5.

Development and validation of a 5-year mortality prediction model using regularized regression and Medicare data.

Lund JL, Kuo TM, Brookhart MA, Meyer AM, Dalton AF, Kistler CE, Wheeler SB, Lewis CL.

Pharmacoepidemiol Drug Saf. 2019 May;28(5):584-592. doi: 10.1002/pds.4769. Epub 2019 Mar 19.

PMID:
30891850
6.

Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.

Assimon MM, Brookhart MA, Flythe JE.

J Am Soc Nephrol. 2019 Apr;30(4):611-623. doi: 10.1681/ASN.2018101032. Epub 2019 Mar 18.

PMID:
30885935
7.

Variation in rotavirus vaccination coding in state US Medicaid data.

Layton JB, Butler AM, Brookhart MA, Panozzo CA.

Vaccine. 2019 May 16;37(22):2892-2895. doi: 10.1016/j.vaccine.2019.02.074. Epub 2019 Mar 12.

PMID:
30876721
8.

Informative censoring by health plan disenrollment among commercially insured adults.

Butler AM, Todd JV, Sahrmann JM, Lesko CR, Brookhart MA.

Pharmacoepidemiol Drug Saf. 2019 May;28(5):640-648. doi: 10.1002/pds.4750. Epub 2019 Feb 20.

PMID:
30788887
9.

Nonparametric Bounds for the Risk Function.

Cole SR, Hudgens MG, Edwards JK, Brookhart MA, Richardson DB, Westreich D, Adimora AA.

Am J Epidemiol. 2019 Apr 1;188(4):632-636. doi: 10.1093/aje/kwz013.

PMID:
30698633
10.

Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population.

Gilbertson DT, Rothman KJ, Chertow GM, Bradbury BD, Brookhart MA, Liu J, Winkelmayer WC, Stürmer T, Monda KL, Herzog CA, Ashfaq A, Collins AJ, Wetmore JB.

J Am Soc Nephrol. 2019 Feb;30(2):346-353. doi: 10.1681/ASN.2018060581. Epub 2019 Jan 24.

PMID:
30679380
11.

Psychotherapy Claims Surrounding Pharmacotherapy Initiation in Children and Adolescents with Anxiety Disorders.

Bushnell GA, Dusetzina SB, Compton SN, Gaynes BN, Brookhart MA, Stürmer T.

J Child Adolesc Psychopharmacol. 2019 Mar;29(2):100-106. doi: 10.1089/cap.2018.0108. Epub 2018 Dec 19.

PMID:
30565956
12.

Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.

Hester LL, Park SI, Wood WA, Stürmer T, Brookhart MA, Lund JL.

Cancer. 2019 Apr 1;125(7):1101-1112. doi: 10.1002/cncr.31821. Epub 2018 Dec 11.

PMID:
30548238
13.

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States.

McGrath LJ, Hernandez RK, Overman R, Reams D, Liede A, Brookhart MA, O'Donnell E.

Cancer Med. 2019 Jan;8(1):374-382. doi: 10.1002/cam4.1869. Epub 2018 Dec 8.

14.

Incidence of mental health hospitalizations, treated self-harm, and emergency room visits following new anxiety disorder diagnoses in privately insured U.S. children.

Bushnell GA, Gaynes BN, Compton SN, Dusetzina SB, Brookhart MA, Stürmer T.

Depress Anxiety. 2019 Feb;36(2):179-189. doi: 10.1002/da.22849. Epub 2018 Oct 24.

PMID:
30358025
15.

Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US.

McGrath LJ, Overman RA, Reams D, Cetin K, Liede A, Narod SA, Brookhart MA, Hernandez RK.

Clin Epidemiol. 2018 Sep 26;10:1349-1358. doi: 10.2147/CLEP.S175063. eCollection 2018.

16.

Timing of Rotavirus Vaccine Doses and Severe Rotavirus Gastroenteritis Among Vaccinated Infants in Low- and Middle-income Countries.

Gruber JF, Becker-Dreps S, Hudgens MG, Brookhart MA, Thomas JC, Jonsson Funk M.

Epidemiology. 2018 Nov;29(6):867-875. doi: 10.1097/EDE.0000000000000909.

PMID:
30074540
17.

Rotavirus vaccination and short-term risk of adverse events in US infants.

Layton JB, Butler AM, Panozzo CA, Brookhart MA.

Paediatr Perinat Epidemiol. 2018 Sep;32(5):448-457. doi: 10.1111/ppe.12496. Epub 2018 Jul 26.

PMID:
30048564
18.

Approaches to Address Premature Death of Patients When Assessing Patterns of Use of Health Care Services After an Index Event.

Bush M, Simpson RJ Jr, Kucharska-Newton A, Fang G, Stürmer T, Brookhart MA.

Med Care. 2018 Jul;56(7):619-625. doi: 10.1097/MLR.0000000000000923.

19.

Examining Parental Medication Adherence as a Predictor of Child Medication Adherence in Pediatric Anxiety Disorders.

Bushnell GA, Brookhart MA, Gaynes BN, Compton SN, Dusetzina SB, Stürmer T.

Med Care. 2018 Jun;56(6):510-519. doi: 10.1097/MLR.0000000000000911.

20.

A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year Mortality Among Individuals Receiving Maintenance Hemodialysis.

Assimon MM, Brookhart MA, Fine JP, Heiss G, Layton JB, Flythe JE.

Am J Kidney Dis. 2018 Sep;72(3):337-348. doi: 10.1053/j.ajkd.2018.02.350. Epub 2018 Apr 10.

PMID:
29653770
21.

Selective prescribing of statins and the risk of mortality, hospitalizations, and falls in aged care services.

Korhonen MJ, Ilomäki J, Sluggett JK, Brookhart MA, Visvanathan R, Cooper T, Robson L, Bell JS.

J Clin Lipidol. 2018 May - Jun;12(3):652-661. doi: 10.1016/j.jacl.2018.02.012. Epub 2018 Mar 2.

PMID:
29574073
22.

Timing and predictors of severe rotavirus gastroenteritis among unvaccinated infants in low- and middle-income countries.

Gruber JF, Becker-Dreps S, Hudgens MG, Brookhart MA, Thomas JC, Jonsson Funk M.

Epidemiol Infect. 2018 Apr;146(6):698-704. doi: 10.1017/S0950268818000626. Epub 2018 Mar 22.

23.

Primary non-adherence and the new-user design.

Li X, Cole SR, Westreich D, Brookhart MA.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):361-364. doi: 10.1002/pds.4403. Epub 2018 Feb 19. No abstract available.

24.

Injection testosterone and adverse cardiovascular events: A case-crossover analysis.

Layton JB, Li D, Meier CR, Sharpless JL, Stürmer T, Brookhart MA.

Clin Endocrinol (Oxf). 2018 May;88(5):719-727. doi: 10.1111/cen.13574. Epub 2018 Mar 6.

25.

On two-stage estimation of structural instrumental variable models.

Choi BY, Fine JP, Brookhart MA.

Biometrika. 2017 Dec;104(4):881-899. doi: 10.1093/biomet/asx056. Epub 2017 Oct 26.

26.

Position matters: Validation of medicare hospital claims for myocardial infarction against medical record review in the atherosclerosis risk in communities study.

Bush M, Stürmer T, Stearns SC, Simpson RJ Jr, Brookhart MA, Rosamond W, Kucharska-Newton AM.

Pharmacoepidemiol Drug Saf. 2018 Oct;27(10):1085-1091. doi: 10.1002/pds.4396. Epub 2018 Feb 6.

PMID:
29405474
27.

Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury.

Christiansen S, Christensen S, Pedersen L, Gammelager H, Layton JB, Brookhart MA, Christiansen CF.

Crit Care. 2017 Dec 28;21(1):326. doi: 10.1186/s13054-017-1903-y.

28.

Association of Household Opioid Availability and Prescription Opioid Initiation Among Household Members.

Seamans MJ, Carey TS, Westreich DJ, Cole SR, Wheeler SB, Alexander GC, Pate V, Brookhart MA.

JAMA Intern Med. 2018 Jan 1;178(1):102-109. doi: 10.1001/jamainternmed.2017.7280.

29.

Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications.

Bushnell GA, Compton SN, Dusetzina SB, Gaynes BN, Brookhart MA, Walkup JT, Rynn MA, Stürmer T.

J Clin Psychiatry. 2018 Jan/Feb;79(1). pii: 16m11415. doi: 10.4088/JCP.16m11415.

30.

Underutilization of Statins When Indicated in HIV-Seropositive and Seronegative Women.

Todd JV, Cole SR, Wohl DA, Simpson RJ Jr, Jonsson Funk M, Brookhart MA, Cocohoba J, Merenstein D, Sharma A, Lazar J, Milam J, Cohen M, Gange S, Lewis TT, Burkholder G, Adimora AA.

AIDS Patient Care STDS. 2017 Nov;31(11):447-454. doi: 10.1089/apc.2017.0145.

31.

Estimating the Effect of Preventable Treatment Discontinuation on Health Outcomes.

Brookhart MA, Reams D, Dluzniewski PJ, Kshirsagar A, Walsh L, Bradbury BD.

Epidemiology. 2018 Jan;29(1):134-141. doi: 10.1097/EDE.0000000000000766.

PMID:
28991002
32.

Reply to: comparative effectiveness medicines research cannot assess efficacy.

Hester LL, Poole C, Suarez EA, Der JS, Anderson OG, Almon KG, Shirke AV, Brookhart MA.

J Clin Epidemiol. 2017 Dec;92:130-132. doi: 10.1016/j.jclinepi.2017.09.009. Epub 2017 Sep 12. No abstract available.

PMID:
28916489
33.

Patterns of Use of Human Papillomavirus and Other Adolescent Vaccines in the United States.

Vielot NA, Butler AM, Brookhart MA, Becker-Dreps S, Smith JS.

J Adolesc Health. 2017 Sep;61(3):281-287. doi: 10.1016/j.jadohealth.2017.05.016. Epub 2017 Jul 22.

PMID:
28739327
34.

The Authors Respond.

Cole SR, Chu H, Brookhart MA, Edwards JK.

Epidemiology. 2017 Nov;28(6):e62-e63. doi: 10.1097/EDE.0000000000000707. No abstract available.

35.

Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States.

Cole SR, Edwards JK, Hall HI, Brookhart MA, Mathews WC, Moore RD, Crane HM, Kitahata MM, Mugavero MJ, Saag MS, Eron JJ; Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) Investigators.

Clin Infect Dis. 2017 Jun 1;64(11):1591-1596. doi: 10.1093/cid/cix199. Erratum in: Clin Infect Dis. 2017 Oct 15;65(8):1431-1433.

36.

Safety of intravenous iron in hemodialysis patients.

Li X, Kshirsagar AV, Brookhart MA.

Hemodial Int. 2017 Jun;21 Suppl 1:S93-S103. doi: 10.1111/hdi.12558. Epub 2017 Apr 3. Review.

37.

Correction: Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis-A Meta-Analysis.

Fisher A, Bassett K, Goel G, Stanely D, Brookhart MA, Freeman HJ, Wright JM, Dormuth CR.

PLoS One. 2017 Feb 15;12(2):e0172646. doi: 10.1371/journal.pone.0172646. eCollection 2017.

38.

Publication of comparative effectiveness research has not increased in high-impact medical journals, 2004-2013.

Hester LL, Poole C, Suarez EA, Der JS, Anderson OG, Almon KG, Shirke AV, Brookhart MA.

J Clin Epidemiol. 2017 Apr;84:185-187. doi: 10.1016/j.jclinepi.2017.01.011. Epub 2017 Feb 8.

39.

Left Truncation Bias to Explain the Protective Effect of Smoking on Preeclampsia: Potential, But How Plausible?

Kinlaw AC, Buckley JP, Engel SM, Poole C, Brookhart MA, Keil AP.

Epidemiology. 2017 May;28(3):428-434. doi: 10.1097/EDE.0000000000000632.

40.

Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.

Winkelmayer WC, Goldstein BA, Mitani AA, Ding VY, Airy M, Mandayam S, Chang TI, Brookhart MA, Fishbane S.

Am J Kidney Dis. 2017 Jun;69(6):771-779. doi: 10.1053/j.ajkd.2016.10.031. Epub 2017 Jan 4.

41.

Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis.

Fisher A, Bassett K, Goel G, Stanely D, Brookhart MA, Freeman HR, Wright JM, Dormuth CR.

PLoS One. 2016 Dec 8;11(12):e0168005. doi: 10.1371/journal.pone.0168005. eCollection 2016. Erratum in: PLoS One. 2017 Feb 15;12 (2):e0172646.

42.

Dogmatists Cannot Learn.

Cole SR, Chu H, Brookhart MA, Edwards JK.

Epidemiology. 2017 Mar;28(2):e10-e11. doi: 10.1097/EDE.0000000000000587. No abstract available.

43.

Nonparametric binary instrumental variable analysis of competing risks data.

Richardson A, Hudgens MG, Fine JP, Brookhart MA.

Biostatistics. 2017 Jan;18(1):48-61. doi: 10.1093/biostatistics/kxw023. Epub 2016 Jun 26.

44.

Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform.

Chertow GM, Liu J, Monda KL, Gilbertson DT, Brookhart MA, Beaubrun AC, Winkelmayer WC, Pollock A, Herzog CA, Ashfaq A, Sturmer T, Rothman KJ, Bradbury BD, Collins AJ.

J Am Soc Nephrol. 2016 Oct;27(10):3129-3138. Epub 2016 Feb 25.

45.

Controlling confounding of treatment effects in administrative data in the presence of time-varying baseline confounders.

Gilbertson DT, Bradbury BD, Wetmore JB, Weinhandl ED, Monda KL, Liu J, Brookhart MA, Gustafson SK, Roberts T, Collins AJ, Rothman KJ.

Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):269-77. doi: 10.1002/pds.3922. Epub 2015 Nov 26.

PMID:
26608680
46.

Misinterpretation of the Comparative Safety of Testosterone Dosage Forms-Reply.

Layton JB, Stürmer T, Brookhart MA.

JAMA Intern Med. 2015 Nov;175(11):1875-6. doi: 10.1001/jamainternmed.2015.5807. No abstract available.

47.

Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective New-user cohort design.

Reams BD, Dluzniewski PJ, Do TP, Yue SV, Bradbury BD, Kshirsagar AV, Brookhart MA.

BMC Nephrol. 2015 Oct 29;16:175. doi: 10.1186/s12882-015-0174-6.

48.

Trends and Determinants of Oral Anti-Diabetic Initiation in Youth with Suspected Type 2 Diabetes.

Cai M, Kappelman MD, Girman CJ, Jain N, Stürmer T, Brookhart MA.

PLoS One. 2015 Oct 28;10(10):e0140611. doi: 10.1371/journal.pone.0140611. eCollection 2015.

49.

Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related Quality of Life in Patients Receiving Hemodialysis.

Freburger JK, Ellis AR, Wang L, Butler AM, Kshirsagar AV, Winkelmayer WC, Brookhart MA.

Am J Kidney Dis. 2016 Feb;67(2):271-82. doi: 10.1053/j.ajkd.2015.09.011. Epub 2015 Oct 23.

PMID:
26508682
50.

Counterpoint: the treatment decision design.

Brookhart MA.

Am J Epidemiol. 2015 Nov 15;182(10):840-5. doi: 10.1093/aje/kwv214. Epub 2015 Oct 26.

Supplemental Content

Loading ...
Support Center